Sarasota Memorial Hospital has earned the #1 spot among the world's WATCHMAN providers protecting people with atrial ...

A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...

Boston Scientific is reaping the rewards from the energised PFA market opportunity in atrial fibrillation treatment.

Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial fibrillation (AF) have been sparsely investigated.Objective To provide a ...

A new study has found that prescribing blood thinners to adults under 65 with atrial fibrillation (AFib) but no other health risks does not help prevent stroke, mini-stroke (TIA), or memory problems.

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.

Cardiovascular Services The Heart Center at St. Mark’s offers a variety of services for people with heart conditions. The ...

Mount Carmel’s heart and vascular teams have debuted several new, highly advanced surgical procedures in Central Ohio.